Diversity of TMPRSS2-ERG fusion transcripts in the human prostate

被引:0
|
作者
J Clark
S Merson
S Jhavar
P Flohr
S Edwards
C S Foster
R Eeles
F L Martin
D H Phillips
M Crundwell
T Christmas
A Thompson
C Fisher
G Kovacs
C S Cooper
机构
[1] Institute of Cancer Research,Department of Pathology
[2] Male Urological Cancer Research Centre,Department of Biological Sciences
[3] ,Department of Urology
[4] Royal Liverpool University Hospital,undefined
[5] The University of Liverpool,undefined
[6] The Royal Marsden NHS Trust Foundation Hospital,undefined
[7] ,undefined
[8] Biomedical Sciences Unit,undefined
[9] Lancaster University,undefined
[10] Royal Devon and Exeter Hospital,undefined
[11] ,undefined
[12] The Royal Marsden NHS Foundation Trust Hospital,undefined
[13] Laboratory of Molecular Oncology,undefined
[14] Medical Faculty,undefined
[15] Reprecht-Karls-University,undefined
[16] ,undefined
来源
Oncogene | 2007年 / 26卷
关键词
prostate cancer; gene; gene; fusion transcripts;
D O I
暂无
中图分类号
学科分类号
摘要
TMPRSS2-ERG gene fusions have recently been reported to be present in a high proportion of human prostate cancers. In the current study, we show that great diversity exists in the precise structure of TMPRSS2-ERG hybrid transcripts found in human prostates. Fourteen distinct hybrid transcripts are characterized, each containing different combinations of sequences from the TMPRSS2 and ERG genes. The transcripts include two that are predicted to encode a normal full-length ERG protein, six that encode N-terminal truncated ERG proteins and one that encodes a TMPRSS2-ERG fusion protein. Interestingly, distinct patterns of hybrid transcripts were found in samples taken from separate regions of individual cancer-containing prostates, suggesting that TMPRSS2-ERG gene fusions may be arising independently in different regions of a single prostate.
引用
收藏
页码:2667 / 2673
页数:6
相关论文
共 50 条
  • [41] Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer
    Urbinati, Giorgia
    Ali, Hafiz Muhammad
    Rousseau, Quentin
    Chapuis, Hubert
    Desmaele, Didier
    Couvreur, Patrick
    Massaad-Massade, Liliane
    PLOS ONE, 2015, 10 (05):
  • [42] Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer
    Furusato, Bungo
    Gao, Chun-Ling
    Ravindranath, Lakshmi
    Chen, Yongmei
    Cullen, Jennifer
    McLeod, David G.
    Dobi, Albert
    Srivastava, Shiv
    Petrovics, Gyorgy
    Sesterhenn, Isabell A.
    MODERN PATHOLOGY, 2008, 21 (02) : 67 - 75
  • [43] TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation
    Sun, C.
    Dobi, A.
    Mohamed, A.
    Li, H.
    Thangapazham, R. L.
    Furusato, B.
    Shaheduzzaman, S.
    Tan, S-H
    Vaidyanathan, G.
    Whitman, E.
    Hawksworth, D. J.
    Chen, Y.
    Nau, M.
    Patel, V.
    Vahey, M.
    Gutkind, J. S.
    Sreenath, T.
    Petrovics, G.
    Sesterhenn, I. A.
    McLeod, D. G.
    Srivastava, S.
    ONCOGENE, 2008, 27 (40) : 5348 - 5353
  • [44] miRNAs as drivers of TMPRSS2-ERG negative prostate tumors in African American men
    Yates, Clayton
    Long, Mark D.
    Campbell, Moray J.
    Sucheston-Campbell, Lara
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2017, 22 : 212 - 229
  • [45] miRNA and TMPRSS2-ERG do not mind their own business in prostate cancer cells
    Fayyaz, Sundas
    Farooqi, Ammad Ahmad
    IMMUNOGENETICS, 2013, 65 (05) : 315 - 332
  • [46] miRNA and TMPRSS2-ERG do not mind their own business in prostate cancer cells
    Sundas Fayyaz
    Ammad Ahmad Farooqi
    Immunogenetics, 2013, 65 : 315 - 332
  • [47] T2E (TMPRSS2-ERG) fusion transcripts are associated with higher levels of AMACR mRNA and a subsequent prostate cancer diagnosis in patients with atypical small acinar proliferation
    Eryilmaz, Isil Ezgi
    Kordan, Yakup
    Vuruskan, Berna Aytac
    Kaygisiz, Onur
    Tunca, Berrin
    Cecener, Gulsah
    GENE, 2018, 645 : 69 - 75
  • [48] Identification of novel somatic fusions of ERG-VEGFA, TMPRSS2-ERG, and VEGFA-TMPRSS2 in prostate cancer treated with anlotinib and androgen deprivation therapy: A case report
    Liu, Qiuli
    Wang, Shuo
    Wang, Ze
    Tang, Peng
    Zhang, Dianzheng
    Lan, Weihua
    Jiang, Jun
    CANCER INNOVATION, 2022, 1 (01): : 114 - 118
  • [49] TMPRSS2-Erg/AR-V7: Prognostic value of tests in urine and biopsy rince material in prostate cancer
    Plante, G.
    Bories, P-N
    Denjean, L.
    Pigat, N.
    Sibony, M.
    Goffin, V
    Delongchamps, N. Barry
    PROGRES EN UROLOGIE, 2020, 30 (03): : 162 - 171
  • [50] TMPRSS2-ERG in Blood and Docetaxel Resistance in Metastatic Castration-resistant Prostate Cancer
    Reig, Oscar
    Marin-Aguilera, Mercedes
    Carrera, Gemma
    Jimenez, Natalia
    Pare, Laia
    Garcia-Recio, Susana
    Gaba, Lydia
    Veronica Pereira, Maria
    Fernandez, Pedro
    Prat, Aleix
    Mellado, Begona
    EUROPEAN UROLOGY, 2016, 70 (05) : 709 - 713